NMH

NMH Annual Report 2024

Issue link: http://digitaleditions.uberflip.com/i/1535709

Contents of this Issue

Navigation

Page 188 of 275

187 NMH | 2024 187 Health and Social Care Professionals Medication Incident Reporting The reporting of incidents is of value as the data collected can be analysed to identify trends or patterns in relation to risk, and resulting recommendations for improvement can be shared with frontline staff. The "Druggle" Ward-Based Medication Safety Huddle initiative was launched in 2024 with the objective of learning from incidents and celebrating what went right in terms of medication incident reporting and medication safety. In 2024 there were 127 medication incident reports submitted compared to 137 in 2023; see Figure 2 below. Again in 2024, the majority of reports were completed by midwifery/nursing staff (59%), with 39% coming from pharmacy staff. A slight decrease in the proportion of reports coming from medical staff was observed (2% in 2024 compared to 4% in 2023). There is a need to both raise awareness of the importance of medication incident reporting among medical staff and facilitate ease of reporting. The proportion of incident reports defined as "near miss" increased slightly to 10% in 2024 compared to 9% in the previous year. Analysis of incident reports found that: • Incidents most commonly occurred at the point of administration (61%) followed by prescribing (25%), storage (10%) and admission/discharge reconciliation (4%) • ' Dose incorrect' was the most common Table 1: Clinical Pharmacy Reviews Performed 2019-2024 2019 2020 2021 2022 2023 2024 Total 13548 21232* 15134 15227 14641 14214 *The figure for clinical pharmacy reviews in 2020 was inflated due to absence of other duties for clinical pharmacists. At the height of the pandemic there was very little scope for projects, quality improvements, audits, and limited changes/updates to policies. Due to this, pharmacists had significantly more time to perform clinical reviews of patients' charts. The figures for 2021 to 2024 represent the normal baseline level of activity. Table 2: Clinical Pharmacy Activity by Area 2024 vs 2023 2024 2023 Antenatal Ward 2634 2,400 Gynae Ward 367 206 Postnatal Ward 1 611 2,271 Postnatal Ward 2 268 171 Postnatal Ward 3 338 372 Maternal Medicine Clinic 648 682 NICU 5386 5,907 Antimicrobial Stewardship 2335 2,284 MN-CMS Prioritisation Review 37 242 Pre-assessment Clinic (PAC) 234 106 MMPT 832 0 Pharmacy Student 524 0 14214 14641 25,000 20,000 15,000 10,000 5000 0 2018 2019 2020 2022 2024 Inpatient Outpatient/Staff Figure 1: Medication Dispensing 2024 2021 2023 Outpatient / Staff as % of Total 18.0% 16.0% 14.0% 12.0% 10.0% 8.0% 6.0% 4.0% 2.0% 0 10.9% 13.0% 17.1% 15.2% 15.8% 15.3% 15.5% reason for a report at 19%, followed by 'administration not documented' at (14%), 'admission/discharge reconciliation not performed' (9%), 'timing of administration incorrect' (8%) and 'duplicate dose administered' (7%) • Antimicrobials accounted for the highest percentage of reports (25%), followed by tinzaparin (18%), paracetamol (8%), insulin (6%), with anti-hypertensives, NSAIDs and Vitamin K all at 5% each David Fitzgerald, Pharmacist Executive Manager.

Articles in this issue

view archives of NMH - NMH Annual Report 2024